Neb. Rev. Stat. §§ 71-9607

Current with changes through the 2024 First Special Legislative Session

Section 71-9607 - Death of patient; effect on debt

If an eligible patient dies while being treated by an investigational drug, biological product, or device, the manufacturer may not seek reimbursement for any outstanding debt related to the treatment or lack of insurance due to the treatment from the eligible patient's or his or her caretaker's estate.

Neb. Rev. Stat. §§ 71-9607

Laws 2018, LB 117, § 7.

Added by Laws 2018, LB 117,§ 7, eff. 7/19/2018.